Calvo Alén

Featured in: Favicon

Articles

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

Aug 3, 2024 | docusalut.com | Calvo Alén

Identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.13003/21019Métricas10.1136/lupus-2023-001064Altabás-González I, Rua-Figueroa I, Mouriño C, Roberts K, Jimenez N, Martinez-Barrio J, et al. Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis. Lupus Sci Med. 2024 Aug 3;11(2).
Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study | Reumatología Clínica

Jun 7, 2023 | reumatologiaclinica.org | Andreu Sánchez |jose luis |Marras Fernández-Cid |Calvo Alén

Introducción y objetivosEl estudio OBSErve España, que forma parte del programa internacional OBSErve, evaluó el uso y la eficacia de belimumab en la práctica clínica real española tras seis meses de tratamiento en pacientes con lupus eritematoso sistémico (LES) activo.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.